oasis trial semaglutide Oral and the Future of GLP-1 Obesity Treatment, With Timothy Garvey, MD oasis 1 trial oral semaglutide

Researchers have so far only reported links to potential eye problems, not a cause and effect

By slowing digestion and reducing hunger signals, Semaglutide and Tirzepatide help patients eat less while still feeling satisfied

Wu BS, Wang Z, Tang Y, et al

The peptide might be cut with fillers

Docosahexaenoic acid (DHA) prevents binge ethanol-dependent aquaporin-4 elevations while inhibiting neurodegeneration: experiments in rat adult-age entorhino-hippocampal slice cultures

In a clinical trial called SUSTAIN-6, Semaglutide was shown to significantly reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, in individuals with type 2 diabetes who were at high risk for cardiovascular disease